+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Gastrin-releasing peptide-, calcitonin gene-related peptide-, and calcitonin-like immunoreactivity in human breast cyst fluid and gastrin-releasing peptide-like immunoreactivity in human breast carcinoma cell lines



Gastrin-releasing peptide-, calcitonin gene-related peptide-, and calcitonin-like immunoreactivity in human breast cyst fluid and gastrin-releasing peptide-like immunoreactivity in human breast carcinoma cell lines



Surgery 106(6): 1134-9; Discussion 1139-40



To assess the role of growth factors in proliferative disorders of the breast, we assayed breast cyst fluid from 70 patients for calcitonin-related peptides. Cyst fluids (5.4 +/- 6.6 ml) (mean +/- SD) (n = 70) contained 10,499 +/- 8272 pg/ml of gastrin-releasing peptide (GRP)-like immunoreactivity in 66 of 70 samples. Calcitonin gene-related peptide (CGRP)-like immunoreactivity was found in 64 of 64 samples tested (3842 +/- 2048 pg/ml). Calcitonin-like immunoreactivity was detected in 47 of 69 samples (185 +/- 106 pg/ml). Significant correlations were found for GRP versus volume, CGRP, and calcitonin, for calcitonin versus volume and CGRP, and for CGRP versus volume. Extracts of two human breast carcinoma cell lines (MCF-7 and BT-20) contained measurable GRP-like immunoreactivity. We conclude that GRP-, CGRP-, and calcitonin-like immunoreactivities are present in human breast cyst fluid and that GRP-like immunoreactivity is present in two established human breast carcinoma cell lines. High concentrations of GRP-like immunoreactivity in both breast cyst fluid and breast carcinoma tissue, taken together with the known mitogenic and trophic activities of this peptide, support the hypothesis that GRP may be an important factor in human breast disease.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 040197305

Download citation: RISBibTeXText

PMID: 2588117


Related references

Vasoactive intestinal polypeptide-, neurotensin-, substance P-, gastrin-releasing peptide-, calcitonin-, calcitonin gene related peptide-, and somatostatin-like immunoreactivities in human parathyroid glands. Surgery 110(6): 1078-1085, 1991

Molecular forms of katacalcin, calcitonin gene-related peptide and gastrin-releasing peptide, in a human medullary thyroid carcinoma. Cancer Research 48(9): 2412-2416, 1988

Calcitonin, calcitonin gene-related peptide, and gastrin-releasing peptide in familial thyroid medullary carcinoma. Surgery 107(2): 182-186, 1990

Co-secretion of calcitonin gene-related peptide, gastrin-releasing peptide and Acth by a carcinoid tumour metastasizing to the cerebellum. Postgraduate Medical Journal 63(736): 123-130, 1987

Co secretion of calcitonin gene related peptide gastrin releasing peptide and acth by a carcinoid tumor metastasizing to the cerebellum. Postgraduate Medical Journal 63(736): 123-130, 1987

Influence of cell growth state on immunoreactive gastrin releasing peptide and iodine 125 labelled gastrin releasing peptide specific binding to membrane associated and cytosolic receptors in human small cell lung carcinoma nci h345 cells. Clinical Research 38(1): 157A, 1990

Immunohistochemical localization of calcitonin gene-related peptide and bombesin/gastrin-releasing peptide in nerve fibers of the rat, guinea pig and pig female genital organs. Histochemistry 92(3): 211-218, 1989

Inhibition of proliferation of human small cell lung cancer cells expressing an autocrine system for gastrin releasing peptide by antisense oligodeoxynucleotides to gastrin releasing peptide receptor. Lung Cancer 36(3): 235-242, 2002

Characterization, in some human breast cancer cell lines, of gastrin-releasing peptide-like receptors which are absent in normal breast epithelial cells. International Journal of Cancer 46(2): 293-298, 1990

Comparison of the actions of bombesin, gastrin-releasing peptide-27, neuromedin B, and gastrin-releasing peptide-10 in causing release of gastrin and gastric inhibitory peptide in rats. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 183(1): 136-139, 1986

Pharmacology and molecular identification of gastrin releasing peptide like receptors in human breast cancer cell lines and normal breast epithelial cells. European Journal of Pharmacology 183(5): 1634, 1990

Coexistence of vasoactive intestinal peptide peptide histidine isoleucine amide and gastrin releasing peptide like immunoreactivity in neurons of the rat suprachiasmatic nucleus. Biomedical Research 7(4): 295-299, 1986

Increase in cytoplasmic Ca2+ and stimulation of calcitonin secretion from human medullary thyroid carcinoma cells by the gastrin-releasing peptide. Biochemical and Biophysical Research Communications 185(3): 833-838, 1992

(99m)Tc]Demomedin C, a radioligand based on human gastrin releasing peptide(18-27): synthesis and preclinical evaluation in gastrin releasing peptide receptor-expressing models. Journal of Medicinal Chemistry 55(19): 8364-8374, 2013

Neurons containing gastrin releasing peptide-like immunoreactivity in the human pancreas. Pancreas 8(4): 403-412, 1993